Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 1.00 |
| ▸ | USP2 | O75604 | 1/20 | 1.00 |
| ▸ | MAPK9 | P45984 | 1/20 | 1.00 |
| ▸ | LMNA | P02545 | 7/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.58 |
| ▸ | MAPT | P10636 | 6/20 | 0.58 |
| ▸ | TP53 | P04637 | 5/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.58 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.58 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.58 |
| ▸ | MITF | O75030 | 3/20 | 0.52 |
| ▸ | MDM2 | Q00987 | 4/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.50 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Furaltadone SCHEMBL49269 | 1.00 | HIF1A (1.00) | HIF1AKMT2AUSP2MAPK9LMNA | |
| Furaltadone SCHEMBL49267 | 1.00 | HIF1A (1.00) | HIF1AKMT2AUSP2MAPK9LMNA | |
| Levofuraltadone SCHEMBL29577077 | 1.00 | HIF1A (1.00) | HIF1AKMT2AUSP2MAPK9LMNA | |
| Furaltadone SCHEMBL11742110 | 1.00 | HIF1A (1.00) | HIF1AKMT2AUSP2MAPK9LMNA | |
| Furaltadone SCHEMBL2585605 | 0.99 | HIF1A (0.98) | HIF1AKMT2AUSP2MAPK9LMNA | |
| Furaltadone SCHEMBL2585607 | 0.99 | HIF1A (0.98) | HIF1AKMT2AUSP2MAPK9LMNA | |
| Furaltadone SCHEMBL14837124 | 0.92 | KMT2A (0.84) | HIF1AKMT2AUSP2MAPK9LMNA | |
| SCHEMBL30869093 | 0.90 | KMT2A (0.82) | HIF1AKMT2AUSP2MAPK9LMNA | |
| SCHEMBL32691021 | 0.90 | KMT2A (0.82) | HIF1AKMT2AUSP2MAPK9LMNA | |
| SCHEMBL32690884 | 0.88 | HIF1A (0.79) | HIF1AKMT2AUSP2MAPK9LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2657 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3851179-B1 | METHOD AND APPARATUS FOR SEPARATING A SYNTHESIS GAS BY CRYOGENIC DISTILLATION | AIR LIQUIDE (FR) | 2026-05-27 | — | — | EP | claimed |
| EP-4630043-A1 | IMMUNE-ACTIVATING COMPLEXES | Dynamic Cell Therapies, Inc. (US) | 2025-10-15 | — | — | EP | claimed |
| EP-4630446-A1 | ENGINEERED SWITCHES FOR IMMUNE CELL ACTIVITY AND METHODS OF USE THEREOF | Dynamic Cell Therapies, Inc. (US) | 2025-10-15 | — | — | EP | claimed |
| EP-4416813-B1 | PARTIAL LOAD SHEDDING FOR ACHIEVING FULL REGENERATIVE SUPPLY OF ELECTRIC LOADS | SIEMENS ENERGY GLOBAL GMBH & CO KG (DE) | 2025-10-08 | — | — | EP | claimed |
| EP-4592388-A1 | BIOMARKER FOR USE IN PREDICTION OF OCCURRENCE OF ACNE VULGARIS, PREDICTION OF SEVERITY AND DETERMINATION OF SEVERITY | The University of Osaka (JP) | 2025-07-30 | — | — | EP | claimed |
| US-20250222066-A1 | COMPOSITIONS AND METHODS OF TREATING, PREVENTING OR INHIBITING A FACULTATIVE ANAEROBE INFECTION | UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2025-07-10 | — | — | US | claimed |
| EP-4547023-A2 | COMPOSITIONS AND METHODS OF TREATING, PREVENTING OR INHIBITING A FACULTATIVE ANAEROBE INFECTION | University of Utah Research Foundation (US) | 2025-05-07 | — | — | EP | claimed |
| US-20250099557-A1 | ANTIBIOTIC PHARMACEUTICAL COMPOSITION CAPABLE OF SUBCUTANEOUS ADMINISTRATION | SHANGHAI BAO PHARMACEUTICALS CO., LTD. (CN) | 2025-03-27 | — | — | US | claimed |
| US-20250090520-A1 | DERIVATIVES OF TURBINMICIN AS ANTIFUNGAL AGENTS | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2025-03-20 | — | — | US | claimed |
| CN-119584992-A | Antibody-drug conjugates comprising antibodies against human TROP2 and uses thereof | 瑞嘉化学生物科学股份有限公司 | 2025-03-07 | — | — | CN | claimed |
| WO-1996012487-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| WO-1996012817-A1 | COMBINATION METHOD FOR ACNE TREATMENT | MERCK & CO., INC. (US) | 1996-05-02 | — | — | WO | claimed |
| US-5482740-A | Sustained release bactericidal cannula | ROCHESTER MEDICAL CORPORATION (US) | 1996-01-09 | — | — | US | claimed |
| EP-0617631-A4 | SUSTAINED-RELEASE BACTERICIDAL CANNULA. | ROCHESTER MEDICAL CORP (US) | 1995-02-22 | — | — | EP | claimed |
| EP-0617631-A1 | SUSTAINED-RELEASE BACTERICIDAL CANNULA | ROCHESTER MEDICAL CORPORATION (US) | 1994-10-05 | — | — | EP | claimed |
| US-5261896-A | Sustained release bactericidal cannula | ROCHESTER MEDICAL CORPORATION (US) | 1993-11-16 | — | — | US | claimed |
| WO-1993011821-A1 | SUSTAINED-RELEASE BACTERICIDAL CANNULA | ROCHESTER MEDICAL CORPORATION (US) | 1993-06-24 | — | — | WO | claimed |
| EP-0025698-B1 | CONTROLLED RELEASE FORMULATIONS | ELI LILLY AND COMPANY (US) | 1984-06-13 | — | — | EP | claimed |
| US-4293539-A | Controlled release formulations and method of treatment | ELI LILLY AND COMPANY (US) | 1981-10-06 | — | — | US | claimed |
| EP-0025698-A2 | Controlled release formulations | ELI LILLY AND COMPANY (US) | 1981-03-25 | — | — | EP | claimed |